Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01449409 · ClinicalTrials.gov registry record · NA
Reduce IDentified UNcontrolled Asthma
A NA study of Asthma, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 1
- Study location
NCT01449409: Active NA study of Asthma, sponsored by Kaiser Permanente.
NCT01449409 is a NA study of Asthma that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 3,000 participants, above the 1,555-participant average among 374 other Asthma trials with a reported enrollment target (93% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01449409, a NA study of Asthma, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of Reduce IDentified UNcontrolled Asthma (RIDUNA) is to determine the benefit of real-time identification of uncontrolled asthma by electronic administrative records linked to real-time notification of uncontrolled status to patients and asthma specialists with recommended guideline directed intervention by physicians. The investigators hypothesize that real-time outreach following National guideline asthma care recommendations, after real-time identification of an uncontrolled asthma event in persistent asthmatics on inhaled corticosteroids will lead to better improvements in asthma control (impairment and risk) compared to standard asthma care outreach.
Primary Outcome
Measure in the follow-up year (1) frequency of patients requiring 2 or more oral corticosteroid courses in cohort with uncontrolled asthma based on risk
Conditions Studied
Interventions
- OTHER Real-time asthma care outreach
Study Locations (1)
California
- Kaiser Permanente Southern California Region - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2011-02-01 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the registry record for NCT01449409 still lists
NCT01449409 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,555-participant average among 374 other Asthma trials with a reported enrollment target (93% higher).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Real-time asthma care outreach is the first listed.
NCT01449409 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01449409 about?
NCT01449409 is a clinical study titled "Reduce IDentified UNcontrolled Asthma". The purpose of Reduce IDentified UNcontrolled Asthma (RIDUNA) is to determine the benefit of real-time identification of uncontrolled asthma by electronic administrative records linked to real-time notification of uncontrolled status to patients and asthma specialists with recommended guideline dire...
What is the current status of trial NCT01449409?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2011-02-01. Estimated completion is 2024-12-31.
What conditions does trial NCT01449409 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01449409?
The interventions under investigation include: Real-time asthma care outreach (OTHER).
Who is sponsoring clinical trial NCT01449409?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01449409 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01449409's enrollment target sits among peer trials
3,000 16th of 374 higher than 357 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI